Stamoulis Christiana 4
4 · Keenova Therapeutics plc · Filed Dec 17, 2025
Insider Transaction Report
Form 4
Stamoulis Christiana
President and CFO
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-15+30,335→ 30,335 total - Exercise/Conversion
Restricted Stock Units
2025-12-15−30,335→ 60,672 total→ Ordinary Shares (30,335 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
- [F2]On September 23, 2025, the reporting person was granted 91,007 RSUs vesting ratably on each of December 15, 2025, December 15, 2026 and December 15, 2027, subject to the Reporting Person's continued service through such date. The number of RSUs held by the reporting person is subject to adjustment in connection with the separation of Par Health, Inc. ("Par Health") from the Issuer on November 10, 2025 pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.